57 related articles for article (PubMed ID: 10585254)
1. Accumulating active p53 in the nucleus by inhibition of nuclear export: a novel strategy to promote the p53 tumor suppressor function.
Laín S; Xirodimas D; Lane DP
Exp Cell Res; 1999 Dec; 253(2):315-24. PubMed ID: 10585254
[No Abstract] [Full Text] [Related]
2. Involvement of nuclear export in human papillomavirus type 18 E6-mediated ubiquitination and degradation of p53.
Stewart D; Ghosh A; Matlashewski G
J Virol; 2005 Jul; 79(14):8773-83. PubMed ID: 15994771
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation.
Kanai M; Hanashiro K; Kim SH; Hanai S; Boulares AH; Miwa M; Fukasawa K
Nat Cell Biol; 2007 Oct; 9(10):1175-83. PubMed ID: 17891139
[TBL] [Abstract][Full Text] [Related]
4. p53 stabilization: the importance of nuclear import.
Marine JC
Cell Death Differ; 2010 Feb; 17(2):191-2. PubMed ID: 20062067
[No Abstract] [Full Text] [Related]
5. Nuclear tumor suppressors in space and time.
Barbie DA; Conlan LA; Kennedy BK
Trends Cell Biol; 2005 Jul; 15(7):378-85. PubMed ID: 15936946
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of COX-2 in colon cancer cell lines by celecoxib increases the nuclear localization of active p53.
Swamy MV; Herzog CR; Rao CV
Cancer Res; 2003 Sep; 63(17):5239-42. PubMed ID: 14500353
[TBL] [Abstract][Full Text] [Related]
7. Heads and tails.Less-active tumor suppressor paradoxically promotes both longevity and cancer in humans.
Beckman M
Sci Aging Knowledge Environ; 2004 Nov; 2004(47):nf104. PubMed ID: 15564560
[No Abstract] [Full Text] [Related]
8. PUMA couples the nuclear and cytoplasmic proapoptotic function of p53.
Chipuk JE; Bouchier-Hayes L; Kuwana T; Newmeyer DD; Green DR
Science; 2005 Sep; 309(5741):1732-5. PubMed ID: 16151013
[TBL] [Abstract][Full Text] [Related]
9. Mutant p53: "gain of function" through perturbation of nuclear structure and function?
Deppert W; Göhler T; Koga H; Kim E
J Cell Biochem Suppl; 2000; Suppl 35():115-22. PubMed ID: 11389540
[TBL] [Abstract][Full Text] [Related]
10. The ins and outs of p53.
Vousden KH; Vande Woude GF
Nat Cell Biol; 2000 Oct; 2(10):E178-80. PubMed ID: 11025676
[No Abstract] [Full Text] [Related]
11. The two faces of tumor suppressor p53.
Smith ML; Fornace AJ
Am J Pathol; 1996 Apr; 148(4):1019-22. PubMed ID: 8644842
[No Abstract] [Full Text] [Related]
12. Lyn: one more actor in the p53 cast?
Rajasekaran B
Cancer Biol Ther; 2002; 1(6):709-10. PubMed ID: 12642698
[No Abstract] [Full Text] [Related]
13. The role of p53 in reproduction, an unexpected function for a tumor suppressor.
Hu W; Feng Z
J Mol Cell Biol; 2019 Jul; 11(7):624-627. PubMed ID: 31310660
[No Abstract] [Full Text] [Related]
14. p53: a tumor suppressor hiding in plain sight.
Baker SJ; Vogelstein B
J Mol Cell Biol; 2019 Jul; 11(7):536-538. PubMed ID: 31276589
[No Abstract] [Full Text] [Related]
15. p53: not just a tumor suppressor.
Oren M
J Mol Cell Biol; 2019 Jul; 11(7):539-543. PubMed ID: 31291648
[No Abstract] [Full Text] [Related]
16. Gluconeogenesis in cancer: door wide open.
Leithner K; Hrzenjak A; Olschewski H
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4394. PubMed ID: 25261555
[No Abstract] [Full Text] [Related]
17. Cell biology and medicine at the crossroads.
Shah ZH
Cell Cycle; 2011 Mar; 10(5):741-4. PubMed ID: 21325878
[No Abstract] [Full Text] [Related]
18. Muscle gets stressed? p53 represses and protects.
Latella L; Puri PL
Cell Death Differ; 2015 Apr; 22(4):519-21. PubMed ID: 25747852
[No Abstract] [Full Text] [Related]
19. Plasmablastic Lymphoma. A State-of-the-Art Review: Part 2-Focus on Therapy.
Bibas M
Mediterr J Hematol Infect Dis; 2024; 16(1):e2024015. PubMed ID: 38468838
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of nuclear export: a promising approach in the shifting treatment paradigms for hematological neoplasms.
Balasubramanian SK; Azmi AS; Maciejewski J
Leukemia; 2022 Mar; 36(3):601-612. PubMed ID: 35091658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
